ResearcherLund UniversityActive in the last 2 years
Lizhi Lin
Matched on ORCID iD 0000-0002-6177-5358; OpenAlex author ID A5014011620. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2024: 1 paper · 2025: 2 papers
Papers 3
- Prognostic model establishment and immune microenvironment analysis based on transcriptomic data of long-term survivors of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.bbrep.2025.102280↗
- A Tissue-based Biomarker Risk Score for Predicting Survival in Pancreatic Ductal Adenocarcinoma. First author DOI 10.21873/cdp.10496↗
- Anoikis-related genes linked with patient outcome in pancreatic cancer. Co-author DOI 10.1016/j.gene.2024.148868↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Roland E. Andersson · 3 shared papers, 2024–2025 · strength 0.84
- Paper Prognostic model establishment and immune microenvironment analysis based on transcriptomic data of long-term survivors… DOI 10.1016/j.bbrep.2025.102280↗
- Paper A Tissue-based Biomarker Risk Score for Predicting Survival in Pancreatic Ductal Adenocarcinoma. DOI 10.21873/cdp.10496↗
- Paper Anoikis-related genes linked with patient outcome in pancreatic cancer. DOI 10.1016/j.gene.2024.148868↗
- Daniel Ansari · 3 shared papers, 2024–2025 · strength 0.84
- Paper Prognostic model establishment and immune microenvironment analysis based on transcriptomic data of long-term survivors… DOI 10.1016/j.bbrep.2025.102280↗
- Paper A Tissue-based Biomarker Risk Score for Predicting Survival in Pancreatic Ductal Adenocarcinoma. DOI 10.21873/cdp.10496↗
- Paper Anoikis-related genes linked with patient outcome in pancreatic cancer. DOI 10.1016/j.gene.2024.148868↗
- Ragnar Norrsell · 2 shared papers, 2025 · strength 0.61
- Monika Posaric Bauden · 2 shared papers, 2024–2025 · strength 0.51
- Xian Shen · 1 shared paper, 2025 · strength 0.33
- Daniel Kříž · 1 shared paper, 2025 · strength 0.28
- Xiangyang Xue · 1 shared paper, 2024 · strength 0.23
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.